Scientists from Colorado State University and the University of São Paulo have overcome a challenge that has prevented ...

HistoSonics, Inc. recently announced the completion of patient enrollment in the #HOPE4KIDNEY pivotal trial of its Edison histotri ...

The MNPR-101 EAP is now open for enrollment to patients with advanced solid tumors at EDNOC in Houston, Texas. EDNOC is among the first private outpatient facilities in the U.S. to be designated as a ...

The U.K.’s National Health Service reported June 10 that patients in the U.K. will be the first in Europe to enjoy the ...

HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today that Addenbrookes Hospital of Cambridge University Hospital Foundation and ...

Doctors and researchers are exploring various approaches to tackle this pervasive health issue, from new medications to dietary interventions. But what if one of the most promising treatments relies ...

Breast cancer is a malignant tumor that occurs in mammary gland tissue. It is the most common cancer in women in Korea, and ...

Scientists developed nanoparticles that respond to warmth inside tumors to boost ultrasound clarity, offering a safer and ...

HistoSonics has completed patient enrollment in a pivitol clinical trial to evaluate its Edison histotripsy system in ...

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors ...

The future of non-invasive cancer therapy is bright. Liver tumors can now be destroyed—without radiation, chemotherapy or surgery—thanks to new medical technology known as histotripsy.